MedPath

Levofloxacin

These highlights do not include all the information needed to use LEVOFLOXACIN safely and effectively. See full prescribing information for LEVOFLOXACIN.LEVOFLOXACIN oral solutionInitial U.S. Approval: 1996

Approved
Approval ID

7e8ff2be-620e-43bf-86d7-78f9d7a5f0ab

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 30, 2018

Manufacturers
FDA

ATLANTIC BIOLOGICALS CORP.

DUNS: 047437707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levofloxacin

PRODUCT DETAILS

NDC Product Code17856-0286
Application NumberANDA091678
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateNovember 30, 2018
Generic NameLevofloxacin

INGREDIENTS (11)

LEVOFLOXACINActive
Quantity: 25 mg in 1 mL
Code: 6GNT3Y5LMF
Classification: ACTIM
ASCORBIC ACIDInactive
Code: PQ6CK8PD0R
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
GRAPEInactive
Code: 6X543N684K
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levofloxacin - FDA Drug Approval Details